Clinical Trial Update: Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of the monoclonal antibody HuHMFG1 in women with locally advanced or metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HuHMFG1 (HuHMFG1)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED